Pituitary gigantism with intracerebral metastases

Endocrinologist

Volumn 9, Issue 6, 1999, Pages 497-501

  Rajasoorya, C ^a   Scheithauer, B W ^b   Tan, L ^c   Young Jr , W F ^b  

^a ALEXANDRA HOSPITAL   (Singapore)

^b MAYO CLINIC   (United States)

^c SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; GROWTH HORMONE; LUTEINIZING HORMONE; OCTREOTIDE; TESTOSTERONE;

ADOLESCENT; ARTICLE; BRAIN METASTASIS; CASE REPORT; DISEASE ASSOCIATION; GIGANTISM; GROWTH HORMONE BLOOD LEVEL; HUMAN; HYPOGONADISM; HYPOPHYSIS TUMOR; INTRACRANIAL PRESSURE; MALE; SYMPTOMATOLOGY; TREATMENT FAILURE;

EID: 0032697673     PISSN: 10512144     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019616-199911000-00012     Document Type: Article

References (31)

1. Zimmerman D, Young WF, Ebersold MJ, et al.: Congenital gigantism due to growth hormone releasing hormone excess and pituitary hyperplasia with adenomatous transformation. J Clin Endocrinol Metab 1993; 76: 216-22.
2. Greenman Y, Woolf P, Coniglio J, et al.: Remission of acromegaly caused by pituitary carcinoma after surgical excision of growth hormone secreting metastasis detected by 111-indium pentetreotide scan. J Clin Endocrinol Metab 1996; 81: 1628-33.
3. Dayan C, Guilding T, Hearing S, et al.: Biochemical cure of recurrent acromegaly by resection of cervical spinal canal metastases. Clin Endocrinol (Oxf) 1996; 44: 597-602.
4. Asai A, Matsutani M, Funada N, et al: Malignant growth-hormone-secreting pituitary adenoma with hematogenous durai metastasis: case report. Neurosurgery 1988; 22: 1091-4.
5. Stewart PM, Carey MP, Graham CT, Wright AD, London DR: Growth hormone secreting pituitary carcinoma: a case report and literature review. Clin Endocrinol (Oxf) 1992: 37: 189-94.
6. Yamashita S, Izumi M, Nagataki S: Acromegaly and pituitary carcinoma (letter). Ann Intern Med 1992; 117: 1057-8.
7. Mountcastle RB, Roof BS, Mayfield RK, et al.: Pituitary adenocarcinoma in an acromegalic patient: response to bromocriptine and pituitary testing - a review of the literature on 36 cases of pituitary carcinoma. Am J Med Sci 1989; 298: 109-18.
8. Hashimoto N, Nanda H, Nishi S: Intracranial and intraspinal dissemination from a growth hormone-secreting pituitary tumor. J Neurosurg 1986; 64: 140-4.
9. Myles ST, Johns RD, Curry B: Clinicopathological conference: carcinoma of the pituitary gland with metastases to bone. Can J Neurol Sci 1984; 11: 310-7.
10. Ogilvy K, Jakubowski J: Intracranial dissemination of pituitary adenomas. J Neurol Neurosurg Psychiatry 1973; 36: 199-205.
11. Newton TH, Burhenne HJ, Palubinskas AJ: Primary carcinoma of the pituitary. Am J Roentgenol 1962; 87: 110-9.
12. Kontchakova J: Metastasen von Tumoren der Hypophyseihre pathologische Anatomic und ihre Klinik. Sovet Psichoneurol 1936; 12: 109-12.
13. Cagnetto G: Zur Frage der anatomischen Beziehung zwischen: Akromegalie und Hypophysistumor. Virchows Arch 1904; 176: 115-68.
14. Cuttler L, Jackson JA, us-Zafar S, et al.: Hypersecretion of growth hormone and prolactin in McCune-Albright syndrome. J Clin Endocrinol Metab 1989; 68: 1148-54.
15. Moran A, Asa SL, Kovacs K, et al.: Gigantism due to pituitary mammosomatotroph hyperplasia. N Engl J Med 1990; 323: 322-7.
16. Daughaday WH: Pituitary gigantism. Endocrinol Metab Clin North Am 1992; 21: 633-17.
17. Klijn JGM, Lamberts SWJ, de Jog FH, van Dongen KJ, Birkenhager JC: Interrelationships between tumour size, age, plasma growth hormone and incidence of extrasellar extension in acromegalic patients. Acta Endocrinol 1980; 95: 289-97.
18. Wrightson P, Rajasoorya C, Holdaway IM, Scott DJ: Acromegaly: factors affecting the long term outcome after surgical treatment. J Clin Neurosci 1994; 1: 164-72.
19. Davis DH, Laws ER, Ilstrup DM, et al.: Results of surgical treatment for growth-hormone secreting pituitary adenomas. J Neurosurg 1993; 79: 70-5.
20. Tindall GT, Oyesiku NM, Watts NB, Clark RV, Christy JH, Adamns DA: Transsphenoidal adenomectomy for growth hormone-secreting adenomas in acromegaly: outcome analysis and determinants of failure. J Neurosurg 1993; 86: 293-9.
21. Pressman BD: Pituitary imaging. In The Pituitary, edited by Melmed S, p. 678, New York, Blackwell Science 1995.
22. Kovacs K, Horvath E: Tumors of the Pituitary Gland. In Fascicle 21, Second Series. Atlas of Tumor Pathology. Washington, DC, Armed Forces Institute of Pathology 1986.
23. Pernicone PJ, Scheithauer BW, Sebo TJ, et al.: Pituitary carcinoma: a clinicopathologic study of 15 cases. Cancer 1997; 79: 804-12.
24. Asa SL, Kovacs K: Pituitary pathology in acromegaly. Endocrinol Metab Clin North Am 1992; 21: 553-74.
25. Thapar K, Kovacs K, Scheithauer BW, et al.: Proliferation activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody. Neurosurgery 1994; 35: 1012-7.
26. Thapar K, Scheithauer BW, Kovacs K, Pernicone PJ, Laws ER Jr: p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions. Neurosurgery 1996; 38: 765-77.
27. Burger PC, Scheithauer BW, Vogen FS: Surgical pathology of the nervous system and its coverings, 3rd edition, pp. 518-521. London, Churchill Livingstone 1990.
28. Doniach I: Pituitary carcinoma (commentary). Clin Endocrinol (Oxf) 1992: 37: 194-5.
29. Kovacs K, Scheithauer BW, Horvath E, Lloyd RV: The World Health Organization classification of adenohypophysial neoplasms. Cancer 1996; 78: 502-10.
30. Jones A: Radiation oncogenesis in relation too the treatment of pituitary tumours. Clin Endocrinol (Oxf) 1991; 35: 379-98.
31. Ezzat S, Melmed S: Are patients with acromegaly at increased risk for neoplasia? J Clin Endocrinol Metab 1991; 72: 245-9.